WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-July-2017 (data as of 19-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 18'0501 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 32'1671 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 10'611  10'604  10'599  10'594  10'587  10'290  10'341  10'349 
Births 108  109  110  111  112  88  127  163 
Surviving infants 108  109  110  111  112  88  125  161 
Pop. less than 5 years 534  552  560  570  578  447  647  896 
Pop. less than 15 years 1'615  1'604  1'582  1'560  1'539  1'690  2'229  2'422 
Female 15-49 years 2'426  2'443  2'465  2'487  2'509  2'610  2'582  2'442 

Number of reported cases

(Click for retrospective incidence data for Czech Republic (the))
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  222  15  22  2'420 
Mumps
ChartChart
  5'734  1'616  677  1'553  3'902  120 
Pertussis
ChartChart
  627  585  2'521  1'233  738  187  48 
Polio*
ChartChart
 
Rubella
ChartChart
  743 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Czech Republic (the))
Vaccine year result method % card seen                                                
BCG          99 
DTP1         
DTP3          96  97  99  98 
DTP4          96  97  99 
IPV1         
HepB_BD         
HepB3          96  97  99  99  99 
Hib3          96  97  99  99  99 
JapEnc         
MCV1          98  99 
MCV2          93  99  96  99  99  97 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          96  97  99  99  99  97 
Rota1         
RotaC         
RCV1          98  99  99  99  98 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Czech Republic (the))
BCG
ChartChart
  98 
DTP1
ChartChart
  98  99  99  99  99  99 
DTP3
ChartChart
  96  97  97  98  99  98 
HepB3
ChartChart
  96  97  99  99  99 
HepB_BD
ChartChart
 
Hib3
ChartChart
  96  97  99  99  99 
MCV1
ChartChart
  98  99  99  99  98  97 
MCV2
ChartChart
  93  99  96  99  99  98 
PCV3
 
Pol3
ChartChart
  96  97  99  99  99  98 
RCV1
ChartChart
  98  99  99  99  98  97 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 86  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 8
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
4
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaP 5 years; Yes
DTaPHibHepIPV 9, 13, 17 weeks; 18 months; Yes
DTaPIPV 10 years; Yes
HPV 13 years; Yes
Influenza_Adult Yes elderly and adults with chronic diseases, health care workers
Influenza_Pediatric Yes Children with chronic diseases
MMR 15, 21 months; Yes
TT 25 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   3 years    3 years  3 years  3 years  3years 
Nº of districts with microplans that include activities to raise immunization coverage number   86  86  86  86  86  86 

System performance

Total Nº districts in country number 86  76  86  86  86  86  86 
Nº districts with DTP3 coverage >=80% number 83  86  86  86  86    86 
% of districts with DTP3 coverage >=80% From 0 to 100% 97  113  100  100  100    100 
Nº districts with measles (MCV1) coverage >=95% number     84  84  86    79 
% of districts with MCV1 coverage >=95% From 0 to 100%     98  98  100    92 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No    No    No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%         NA     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.